Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Blueprint Medicines
Blueprint Medicines
(BPMC)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ayvakit
Avapritinib
2020-01-09
2034
Gastrointestinal stromal tumors
Ayvakyt
Avapritinib
2020-09-24
2034
Gastrointestinal stromal tumors
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Avapritinib
neoplasms
,
hematologic neoplasms
,
mast-cell leukemia
,
central nervous system neoplasms
,
gastrointestinal stromal tumors
,
systemic mastocytosis
,
mastocytosis
Benzodiazepine
germ cell and embryonal neoplasms
Bevifimod
healthy volunteers/patients
,
type 1 diabetes mellitus
,
insulin resistance
,
neoplasms
,
sarcoma
,
melanoma
,
squamous cell carcinoma of head and neck
,
multiple myeloma
,
head and neck neoplasms
,
endometriosis
,
t-cell lymphoma peripheral
,
celiac disease
,
protein c deficiency
,
plasma cell neoplasms
,
neoplasm metastasis
,
rheumatoid arthritis
,
sleep initiation and maintenance disorders
,
intrinsic sleep disorders
,
granulosa cell tumor
,
wounds and injuries
,
traumatic brain injuries
,
craniocerebral trauma
,
brain injuries
,
squamous cell carcinoma
,
squamous cell neoplasms
,
subarachnoid hemorrhage
,
colorectal neoplasms
,
chronic renal insufficiency
,
chronic kidney failure
,
anemia
,
hemophilia a
,
hypertension
,
von willebrand diseases
,
non-small-cell lung carcinoma
,
diabetes mellitus
,
primary immunodeficiency diseases
,
essential hypertension
,
leiomyoma
,
myofibroma
,
covid-19
,
ulcerative colitis
,
type 2 diabetes mellitus
,
thrombotic thrombocytopenic purpura
,
cardiovascular diseases
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
philadelphia chromosome
,
lymphoid leukemia
,
lung neoplasms
,
osteoporosis
,
viral pneumonia
,
glucose metabolism disorders
,
dyslipidemias
,
prostatic neoplasms
,
adenocarcinoma
,
immunization
,
ischemic stroke
,
large b-cell lymphoma diffuse
,
interdigitating dendritic cell sarcoma
,
chronic inflammatory demyelinating polyradiculoneuropathy
,
hodgkin disease
,
lymphoma
,
large-cell lymphoma anaplastic
,
crohn disease
,
precocious puberty
,
non-hodgkin lymphoma
,
recurrence
,
alpha 1-antitrypsin deficiency
,
t-cell lymphoma
,
hematologic diseases
,
chronic obstructive pulmonary disease
,
mucopolysaccharidoses
,
mucopolysaccharidosis i
,
mucopolysaccharidosis ii
,
hemarthrosis
Sugemalimab
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use